
BPC/TB-500
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterThe Ultimate Recovery Combo
Dual-action recovery blend combining targeted repair with systemic anti-inflammation.
Choose your supply
Extra 10% off your first order · use code WELCOME10 at checkout (stacks with the supply discount above).
Frequently paired with
What it supports
- Targeted + systemic tissue repair
- Accelerated injury recovery
- Reduced inflammation body-wide
- Enhanced tendon, ligament, and muscle healing
- Improved joint mobility
- Gut healing support
- Faster post-surgical recovery
The details
- Administration
- Subcutaneous injection
- Format
- 3mg/mL (BPC-157) + 5mg/mL (TB-500), 5mL vial
- Typical dosing
- Per provider guidance, subcutaneous injection daily
- Best for
- Injury recovery, post-surgery healing, tissue repair
- Pairs well with
- CJC-1295/Ipamorelin, GHK-Cu
- Mechanism
- BPC-157 promotes angiogenesis and growth factor recruitment at the injury site while TB-500 upregulates actin for cell migration and systemic inflammation reduction. Together they cover both local and whole-body repair pathways.
How it works
Signal
BPC/TB-500 is given as a single daily subcutaneous injection on a provider-determined schedule.
Cellular response
BPC-157 promotes angiogenesis and growth-factor recruitment at the injury site, while TB-500 upregulates actin for cell migration and reduces systemic inflammation. Together they cover both local and whole-body repair pathways.
Outcome
Over the following weeks most people notice pain, stiffness, and swelling drop first — gut symptoms easing too if relevant (weeks 1–2), then real mobility and faster workout recovery (weeks 2–4), then the injured area feeling stable and strong, not just less painful (weeks 4–8), with full return to activity from week 8 onward.
Sources & references
BPC-157 accelerates tendon healing
Chang CH et al. J Appl Physiol. 2011;110(3):774–780.
View sourceTB-500 promotes tissue repair (review)
Goldstein AL et al. Ann N Y Acad Sci. 2012;1270:1–8.
View sourceComplementary mechanisms support combination use
Sikiric P et al. Curr Pharm Des. 2019;25(12):1362–1367.
View sourceThymosin beta-4 in tissue repair
Annals of the New York Academy of Sciences, 2010
View sourceTB-500 effects on wound healing
Expert Opinion on Biological Therapy, 2015
View sourceBPC-157 angiogenic activity
Journal of Applied Physiology, 2011
View sourceCombined peptide approaches in regenerative medicine
Regenerative Medicine, 2021
View source
Common questions
Important safety information
BPC/TB-500 is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • Generally well tolerated
- • Possible injection site reactions
- • Not for use with active cancer
- • Requires licensed provider supervision


